Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS

Manuel I. Hermosilla, Jorge A. Lemus

NBER Working Paper No. 23989
Issued in November 2017, Revised in March 2018

---- Acknowledgments ----

Previously circulated as "Therapeutic Translation in the Wake of the Genome." We thank Ernst Berndt, Dana Goldman, and John Rowe, and the participants of the NBER conference on Economic Dimensions of Personalized and Precision Medicine. Errors and omissions are our own. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page